About
Immuno-Oncology, Dendritic Cell Treatment
Areas of Focus
Categories
Stem Cell & Cellular TherapySouthwestern U.S.
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
198
By Phase
PHASE2: 1PHASE1: 1
By Status
RECRUITING: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
Today
Hover over trial bars to see details
Recent Trials
NCT06805305Lead Sponsor
DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
PHASE2Recruiting
180 participants
Started: Mar 17, 2025 · Completed: Mar 31, 2032
NCT04157127Lead Sponsor
Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma
PHASE1Recruiting
18 participants
Started: Aug 3, 2020 · Completed: Dec 31, 2027
Locations (1)
Headquarters
Houston, TX, United States
Map
Loading map...